KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Total Non-Current Liabilities (2016 - 2026)

Edwards Lifesciences has reported Total Non-Current Liabilities over the past 17 years, most recently at $2.9 billion for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities rose 9.08% year-over-year to $2.9 billion; the TTM value through Dec 2025 reached $2.9 billion, up 9.08%, while the annual FY2025 figure was $2.9 billion, 9.08% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $2.9 billion at Edwards Lifesciences, up from $2.7 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $3.0 billion in Q3 2024 and troughed at $2.2 billion in Q2 2022.
  • A 5-year average of $2.5 billion and a median of $2.5 billion in 2021 define the central range for Total Non-Current Liabilities.
  • Biggest five-year swings in Total Non-Current Liabilities: grew 16.61% in 2021 and later dropped 10.95% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $2.4 billion in 2021, then rose by 2.51% to $2.5 billion in 2022, then rose by 7.49% to $2.6 billion in 2023, then decreased by 0.93% to $2.6 billion in 2024, then rose by 9.08% to $2.9 billion in 2025.
  • Business Quant data shows Total Non-Current Liabilities for EW at $2.9 billion in Q4 2025, $2.7 billion in Q3 2025, and $2.5 billion in Q2 2025.